Leerink Partners Has Lowered Expectations for Lexeo Therapeutics (NASDAQ:LXEO) Stock Price
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective dropped by Leerink Partners from $19.00 to $18.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Leerink Partners’ price objective would suggest a potential upside of 305.41% from the stock’s current price. Separately, Royal Bank […]
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective dropped by Leerink Partners from $19.00 to $18.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Leerink Partners’ price objective would suggest a potential upside of 305.41% from the stock’s current price. Separately, Royal Bank […]
